Eczema Clinical Research Studies
BIOLOGIC INJECTION STUDY
ELI LILLY AD
The main purpose of this study is to learn whether an investigational drug (also known as the “study drug”) called lebrikizumab could impact how effective certain vaccines may be and how effective and safe the study drug is in patients with moderate-to-severe AD compared with placebo.
ORAL MEDICATION STUDY
The main purpose of this study is to see if difelikeafalin oral tablets (taken by mouth) can reduce the intensity of itching and whether it is well tolerated in subjects with atopic dermatitis and moderate to severe pruritus. Atopic dermatitis is commonly known as eczema, pruritus is commonly known as itchy skin.
Investigational Topical Therapy
The purpose of this trial is to find out if the delgocitinib cream is safe when used in adults, adolescents, and children. Delgocitinib is believed to interfere with the activity of an enzyme called Janus Kinase (JAK), which is involved in the immune response in your body.
The purpose of this study is to evaluate the effect of an investigational drug called Tradipitant on symptoms associated with atopic dermatitis with atopic dermatitis and to assess the safety of Tradipitant.